Canaccord Genuity Maintains Buy on Merit Medical Systems, Lowers Price Target to $102
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Jon Young maintains a Buy rating on Merit Medical Systems (MMSI) but lowers the price target from $112 to $102.

May 01, 2024 | 6:54 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Canaccord Genuity maintains a Buy rating on Merit Medical Systems but lowers the price target from $112 to $102.
While the reduction in price target could suggest a tempered outlook on the stock's short-term price performance, the maintenance of a Buy rating indicates a continued positive view on the company's fundamentals. This mixed signal could lead to a neutral short-term impact on the stock price as investors weigh the lowered price target against the analyst's ongoing endorsement.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100